Kincellis Advanced Therapies Appoints Bruce Thompson as Chief Scientific Officer
PRIVATEOct 02, 2026
Position
Chief Scientific Officer
Company
Kincellis Advanced Therapies
Bruce Thompson
ManufacturingBiotechnology
Description
Kincellis Advanced Therapies has appointed Bruce Thompson, Ph.D., as Chief Scientific Officer. He will lead the company’s technical organization and CMC strategy as part of the newly merged cell therapy CDMO.
Company Information
Company
Kincellis Advanced Therapies
About
Kincellis Advanced Therapies is a U.S.-based CDMO that supports advanced-therapy developers from early-stage CMC, process and analytical development through clinical supply, pivotal-stage programs and commercial manufacturing. The company operates roughly 140,000 square feet of development and manufacturing space across three U.S. sites.
Fundz sees it the moment Kincellis Advanced Therapies changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.